课题基金 / 基金详情

Molecular Biological Analysis for Mechanism of Thombosis Regulation and Its APlication for Clinical Desease.

Molecular Biological Analysis for Mechanism of Thombosis Regulation and Its APlication for Clinical Desease.
血栓形成调节机制的分子生物学分析及其在临床疾病中的应用。
批准号:
07457231
负责人:
SAITO Hidehiko
金额:
$4.61万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

SAITO Hidehiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To determine the subcellular localization of the protein C (PC) Nagoya, an elongated variant of the human PC,the recombinant PC bearing this mutation was expressed in Chinese hamster ovary cells. Immunoelectron microscopy indicated that PC Nagoya was relained in the ER,whereas wild type PC was observed in both the ER and the Golgi apparatus. Metabolic radiolabeling with [35S] methionine in combination with chemical cross-linking revealed that the PC Nagoya existed in the ER as an complex with GRP78 and GRP94. Because both GRP78 and GRP94 associate far lesser degree with wild type PC than with PC Nagoya, our data suggest that both stress proteins function as molecular chaperones, and work in concert with the folding and assembly of PC.DNA sequence analysis in the proband with a hereditary type I protein S (PS) deficiency showed a novel missense mutation substituting Cys (TGT) for Arg474 (CGT). Stable expression and pulse-chase experiments demonstrated an intracellular degradation and an impaired secretion of the recombinant Cys-mutant PS.Furthermore, the substitution of Arg 474 by Ala or Clu, but not Lys. markedly reduced the secretion of the recombinant PS mutant, suggesting that a positively charged basic amino acid might be needed at residue 474 and might play a key role in the protein structure and conformation of the sex hormone binding globulin-homology domain of the PS molecule.It was found that basic fibroblast growth factor (bFGF), midkine (MK), and tissue factor pathway inhibitor (TFPI) exhibited significant ryudocan binding through its heparan sulfate chains. Immuno-histochemical analysis revealed that ryudocan was expressed in peripheral nerve tissues, fibrous connective tissues, and placental trophoblasts. These observations suggest that ryudocan may possess multiple biologic functions, such as bFGF modulation, neurite growth promotion, and anticoagulation, via heparan sulfate binding effectors present in the cellular microenvironment.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
H. Toyozumi, H. Saito, et al.: "Diagnosis of Hemophilia B Carriers Using Two Novel Dinucleotide Polymorphisms and Hha I RFLP of the Factor IX Gene in Japanese Subjects." Thromb. Haemost.74(4). 1009-1014 (1995)
H. Toyozumi、H. Saito 等人:“使用日本受试者中因子 IX 基因的两种新型二核苷酸多态性和 Hha I RFLP 诊断 B 型血友病携带者”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T. Kojima, H. Saito, et al.: "Human Ryudocan from Endothelium-like Cells Binds Basic Fibroblast Growth Factor, Midkine, and Tissue Factor Pathway Inhibitor." J. Biol. Chem.271(10). 5914-5920 (1996)
T. Kojima、H. Saito 等人:“来自内皮样细胞的人 Ryudocan 结合碱性成纤维细胞生长因子、中期因子和组织因子途径抑制剂。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Elucidation of molecular basis of May-Hegglin anomaly and its related disordes
    Down-regulation of murine tissue factor pathway inhibitor mRNA by endotoxin and tumor neerosis factor-alpha In vitro and In vivo.
    • 批准号:
      11470209
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $9.41万
    • 财政年份:
      1999
    • 负责人:
      SAITO Hidehiko
    • 依托单位:
    Novel immunotherapy for Hematological Malignancy
    • 批准号:
      11557074
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $8.38万
    • 财政年份:
      1999
    • 负责人:
      SAITO Hidehiko
    • 依托单位:
    Molecular Biological Analysis for Mechanism of Thombosis Regulation and Its Aplication for Clinical Desease.
    • 批准号:
      09470228
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.94万
    • 财政年份:
      1997
    • 负责人:
      SAITO Hidehiko
    • 依托单位:
    海外基金